{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:42:34Z","timestamp":1761514954347,"version":"3.37.3"},"reference-count":8,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,1,4]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>\nRespiratory distress syndrome (RDS) or surfactant deficiency occurs primarily in premature infants resulting in composite outcomes of death or bronchopulmonary dysplasia. Initial management strategies for preterm infants with RDS includes early initiation of continuous positive airway pressure (CPAP) and titration of fractional inspired oxygen (FiO\n<jats:sub>2<\/jats:sub>\n), and may include the use of less invasive surfactant administration (LISA) to avoid the need for mechanical ventilation. In order to optimise success of non-invasive support, the use of early caffeine therapy may be critical to the success of LISA. The objective of our trial is to evaluate whether infants that receive early caffeine, CPAP and surfactant via the LISA method compared with infants that receive caffeine and CPAP alone, have a decreased need for invasive mechanical ventilation in the first 72 hours of life.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods and analysis<\/jats:title>\n<jats:p>\nCaLI is an unblinded multicentre, randomised controlled, trial of 180 preterm infants (24+0\u201329+6 weeks corrected GA). Criteria for intubation\/treatment failure will follow guidelines for the management of RDS, including: (1) CPAP level of 6\u20138 cmH20 and FiO\n<jats:sub>2<\/jats:sub>\n&gt;0.40 required to maintain saturations 90%\u201395% for 2\u2009hours after randomisation; (2) a pH of 7.15 or less or a paCO\n<jats:sub>2<\/jats:sub>\n&gt;65\u2009mm Hg on any (2) blood gases (arterial\/capillary\/or venous) at least 2\u2009hours after randomisation and in the first 72 hours of life; (3) continued apnoea\/bradycardia\/desaturation events despite nasal intermittent minute ventilation mode of ventilation. Infants will be randomised by 1\u2009hour of life and caffeine\/LISA treatments administered by 2\u2009hour of life. Caffeine will be administered prior to surfactant in the LISA arm and before 2\u2009hours of life in the control arm.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Ethics and dissemination<\/jats:title>\n<jats:p>Chiesi Farmaceutici, S.p.A is the sponsor of CaLI. Ethical approval has been obtained. Results will be submitted for publication in peer reviewed journals.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Trial registration number<\/jats:title>\n<jats:p>\n<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"www.Clinicaltrials.gov\">www.Clinicaltrials.gov<\/jats:ext-link>\n:\n    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT04209946\">NCT04209946<\/jats:ext-link>; Pre-results\n.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038343","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T14:29:24Z","timestamp":1667572164000},"page":"e038343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04209946","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"given":"Felix","family":"Ines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shandee","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamika","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherry","family":"Uy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Finer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Steen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9352-0934","authenticated-orcid":false,"given":"Anup C","family":"Katheria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"2024101904363206000_11.1.e038343.1","doi-asserted-by":"publisher","DOI":"10.1159\/000499361"},{"key":"2024101904363206000_11.1.e038343.2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamapediatrics.2015.0504","article-title":"Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial","volume":"169","author":"Kribs","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2024101904363206000_11.1.e038343.3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/pr.2017.45","article-title":"Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial","volume":"82","author":"Dekker","year":"2017","journal-title":"Pediatr Res"},{"key":"2024101904363206000_11.1.e038343.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60986-0"},{"key":"2024101904363206000_11.1.e038343.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10708"},{"key":"2024101904363206000_11.1.e038343.6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41372-018-0302-9","article-title":"The use of less invasive surfactant administration (LISA) in the United States with review of the literature","volume":"39","author":"Kurepa","year":"2019","journal-title":"J Perinatol"},{"key":"2024101904363206000_11.1.e038343.7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/apa.14995","article-title":"Survey of less invasive surfactant administration in England, slow adoption and variable practice","volume":"109","author":"Bhayat","year":"2020","journal-title":"Acta Paediatr"},{"key":"2024101904363206000_11.1.e038343.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911783"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:41:38Z","timestamp":1729582898000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,22]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bmjopen-2020-038343"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038343","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}